Form 4: Alnylam Pharmaceuticals Executive Receives Stock Options and Restricted Stock Units

Tolga Tanguler, EVP and Chief Commercial Officer of Alnylam Pharmaceuticals, reports the acquisition of stock options and restricted stock units (RSUs) in a recent Form 4 filing.

Summary

• Tolga Tanguler, EVP and Chief Commercial Officer of Alnylam Pharmaceuticals, filed a Form 4 detailing changes in beneficial ownership.
• On March 1, 2024, Tanguler acquired 4,751 restricted stock units (RSUs) and 9,279 stock options.
• The RSUs vest over a three-year period, with one-third vesting annually, contingent upon continued service.
• The stock options vest 25% on the first anniversary of the grant date, with the remaining shares vesting in equal installments quarterly thereafter until the fourth anniversary, also subject to continued service.
• The exercise price for the stock options is $152.61.
• Following the reported transactions, Tanguler beneficially owns 9,987 shares of common stock, including previously reported RSUs and shares, and 9,279 stock options.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices, incentivizing performance and retention.

Positives

• The grant of RSUs and stock options aligns the executive's interests with those of the shareholders.
• The vesting schedules incentivize continued service and commitment to the company.

Industry Context

Executive compensation through stock options and RSUs is a common practice in the pharmaceutical industry to incentivize performance and retain key personnel.

Comparison to Industry Standards

• Stock option and RSU grants are standard compensation practices in the pharmaceutical industry.
• Companies like Amgen, Gilead, and Biogen also utilize similar equity-based compensation plans for their executives.
• Vesting schedules of three to four years are typical to ensure long-term commitment.

Stakeholder Impact

• The equity grants align executive interests with shareholder value.
• Employees may be motivated by the potential for similar compensation opportunities.

Key Dates